Market Tracker

12/22 9:53am ET

PowerShares Dynamic Pharmaceuticals Portfolio (PJP)

Data as of 9:38am ET
 -0.88 / -1.25%
Today’s Change
Today|||52-Week Range
PJP Regular Dividend: PJP began trading ex-dividend on 12/19/14. A $0.091 dividend will be paid to shareholders of record as of 12/23/14.

Investment Objective

The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dynamic Pharmaceuticals IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of pharmaceutical companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 30 U.S. pharmaceuticals companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. It is non-diversified.

No recent news for PowerShares Dynamic Pharmaceuticals Portfolio.


1 month+4.65% 3 years+38.64%
3 months+9.33% 5 years+32.23%
1 year+35.20% Since inception+18.72%
Data through 12/20/2014

Quote Details

Previous close$70.38
Open day’s range69.12 – 69.96
Net asset value (NAV)70.42 (12/19/2014)
Daily volume31,862
Average volume (3 months)208,602
Data as of 9:38am ET, 12/22/2014

Peer Comparisonvs. Health ETFs

Performance 5-yr return+32.23%+21.83%
Expense Gross exp ratio0.58%0.44%
Risk 5 year sharpe ratio2.121.50
Net assets$1.5B$1.6B
Average market cap$21.0B$34.2B
Average P/E27.925.9
Dividend / Share--0.21%


VHT Vanguard Health Care Index Fund ETF Shar...
XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 97.52%
Consumer goods 2.48%
Business service 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
CELG Celgene Corp5.47%
AMGN Amgen Inc5.42%
AUXL Auxilium Pharmaceuticals Inc5.36%
BMY Bristol-Myers Squibb Company5.33%
PFE Pfizer Inc4.84%
JNJ Johnson & Johnson4.77%
MRK Merck & Co Inc4.59%
GILD Gilead Sciences Inc4.26%
BIIB Biogen Idec Inc4.10%
AGN Allergan Inc3.77%